BSE filing, BSE: 544160. Summary written from the filing by ALFA Finder's alert engine.
Jay Kailash Namkeen Ltd: key numbers
- Share price
- ₹48.22
- Market cap
- ₹24.10 Cr
- Revenue (annual)
- ₹17.46 Cr
- Net profit (annual)
- ₹1.20 Cr
- P/E (TTM)
- 20.0×Sector 38.3×
- Promoter holding
- 20.32%
- FII holding
- 2.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jay Kailash Namkeen Ltd
All →Jay Kailash Namkeen Other Announcement
The company filed a compliance certificate under SEBI Regulation 74(5) for the quarter and half-year ended September 30, 2026.
Jay Kailash Namkeen Open Offer
Jay Kailash Namkeen Ltd constituted a Committee of Independent Directors to provide recommendations on the upcoming Open Offer by Mr. Amar Pramod Talwar.
Jay Kailash Namkeen Management Change
Jay Kailash Namkeen Limited has appointed M/s. MRB & Associates as the new statutory auditor. The company also announced various changes in its board of directors.
Jay Kailash Namkeen Annual General Meeting
Jay Kailash Namkeen held its 5th AGM on September 12, 2026, approving the reappointment of Mr. Neel Pujara, the Statutory Auditor, and several new directors.
Jay Kailash Namkeen Annual General Meeting
Jay Kailash Namkeen held its 5th Annual General Meeting on September 12, 2026. Shareholders approved standard items and a preferential equity issuance of Rs. 15.25 Crore.
- Value
- ₹15.25 Cr
Jay Kailash Namkeen Open Offer
Mr. Amar Pramod Talwar announced an open offer to acquire 26% of Jay Kailash Namkeen Limited. This follows a preferential allotment and share swap agreement.
Other other announcement announcements
All →KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.